{"id":"NCT05133180","sponsor":"Dompé Farmaceutici S.p.A","briefTitle":"Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)","officialTitle":"A 4-week, Phase III, Multicenter, Double-masked, Vehicle-controlled Clinical Study to Evaluate Safety and Efficacy of Oxervate® (Cenegermin) 20 mcg/mL Ophthalmic Solution vs Vehicle in Severe Sjogren's Dry Eye Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-01-19","primaryCompletion":"2022-09-22","completion":"2022-12-19","firstPosted":"2021-11-24","resultsPosted":"2024-06-07","lastUpdate":"2024-06-07"},"enrollment":104,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye"],"interventions":[{"type":"DRUG","name":"Oxervate","otherNames":["Cenegermin"]},{"type":"OTHER","name":"Vehicle","otherNames":["Reference product"]}],"arms":[{"label":"Oxervate","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"Primary objectives\n\n* To compare the efficacy of cenegermin vs vehicle in Schirmer I test (without anaesthesia) \\>10mm/5min at Week 4 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in Symptom Assessment in Dry Eye questionnaire (SANDE) global score at Week 12 by testing the superiority.\n\nSecondary objectives\n\n* To compare the efficacy of cenegermin vs vehicle in Schirmer I test at Week 4, 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in Cornea and conjunctiva vital staining with fluorescein (National Eye Institute \\[NEI\\] scales) at Week 4, 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in Tear Film Break-Up Time (TFBUT) at Week 4, 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in SANDE scores at Week 8, 12 and 16 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in worsening in symptom scores (SANDE) and/or NEI score at Week 4 by testing the superiority.\n* To compare the efficacy of cenegermin vs vehicle in impact of dry eye on everyday life (IDEEL) questionnaire at Week 4, 8, 12 and 16 by testing the superiority.","primaryOutcome":{"measure":"Number of Patients Reaching a Value of Schirmer I Test (Without Anaesthesia) >10mm/5min at Week 4","timeFrame":"at week 4","effectByArm":[{"arm":"Oxervate (FAS)","deltaMin":19,"sd":null},{"arm":"Vehicle (FAS)","deltaMin":2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States","Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":52},"commonTop":["Eye pain - Mild","Eye pain - Moderate","Eyelid pain - Mild","Eye pruritus - Mild","Eyelid pain - Moderate"]}}